A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...

Patient advocacy groups had decried the firings, and lobbying groups rushed to save some slots that were in part funded by ...

A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.

Hims & Hers Health shares were headed for their biggest single-day plunge as Wall Street analysts questioned the telehealth ...

Key Takeaways Eli Lilly lowered the price of two dosage levels of its weight-loss drug Zepbound for patients paying out of ...

Those rehired by the Trump administration include at least 10 FDA staffers responsible for reviewing the safety of new food ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...

The National Agency for Food and Drug Administration, NAFDAC, will today, February 26, unseal all the sections of Ariaria International ...

The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...

China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price. But this disruptive trend ...